These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 30019481

  • 1. Crystal structure of plasma kallikrein reveals the unusual flexibility of the S1 pocket triggered by Glu217.
    Xu M, Chen Y, Xu P, Andreasen PA, Jiang L, Li J, Huang M.
    FEBS Lett; 2018 Aug; 592(15):2658-2667. PubMed ID: 30019481
    [Abstract] [Full Text] [Related]

  • 2. Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein.
    Tang J, Yu CL, Williams SR, Springman E, Jeffery D, Sprengeler PA, Estevez A, Sampang J, Shrader W, Spencer J, Young W, McGrath M, Katz BA.
    J Biol Chem; 2005 Dec 09; 280(49):41077-89. PubMed ID: 16199530
    [Abstract] [Full Text] [Related]

  • 3. Structure of plasma and tissue kallikreins.
    Pathak M, Wong SS, Dreveny I, Emsley J.
    Thromb Haemost; 2013 Sep 09; 110(3):423-33. PubMed ID: 23494059
    [Abstract] [Full Text] [Related]

  • 4. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
    Shia S, Stamos J, Kirchhofer D, Fan B, Wu J, Corpuz RT, Santell L, Lazarus RA, Eigenbrot C.
    J Mol Biol; 2005 Mar 11; 346(5):1335-49. PubMed ID: 15713485
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
    Katz BA, Liu B, Barnes M, Springman EB.
    Protein Sci; 1998 Apr 11; 7(4):875-85. PubMed ID: 9568894
    [Abstract] [Full Text] [Related]

  • 6. Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition.
    Partridge JR, Choy RM, Silva-Garcia A, Yu C, Li Z, Sham H, Metcalf B.
    J Struct Biol; 2019 May 01; 206(2):170-182. PubMed ID: 30876891
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
    Laxmikanthan G, Blaber SI, Bernett MJ, Scarisbrick IA, Juliano MA, Blaber M.
    Proteins; 2005 Mar 01; 58(4):802-14. PubMed ID: 15651049
    [Abstract] [Full Text] [Related]

  • 10. A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex.
    Mittl PR, Di Marco S, Fendrich G, Pohlig G, Heim J, Sommerhoff C, Fritz H, Priestle JP, Grütter MG.
    Structure; 1997 Feb 15; 5(2):253-64. PubMed ID: 9032072
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA.
    Carvalho AL, Sanz L, Barettino D, Romero A, Calvete JJ, Romão MJ.
    J Mol Biol; 2002 Sep 13; 322(2):325-37. PubMed ID: 12217694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structure of granzyme C reveals an unusual mechanism of protease autoinhibition.
    Kaiserman D, Buckle AM, Van Damme P, Irving JA, Law RH, Matthews AY, Bashtannyk-Puhalovich T, Langendorf C, Thompson P, Vandekerckhove J, Gevaert K, Whisstock JC, Bird PI.
    Proc Natl Acad Sci U S A; 2009 Apr 07; 106(14):5587-92. PubMed ID: 19299505
    [Abstract] [Full Text] [Related]

  • 14. Prediction of substrate specificity in NS3/4A serine protease by biased sequence search threading.
    Ozdemir Isik G, Ozer AN.
    J Biomol Struct Dyn; 2017 Apr 07; 35(5):1102-1114. PubMed ID: 27122119
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative thermal unfolding study of psychrophilic and mesophilic subtilisin-like serine proteases by molecular dynamics simulations.
    Du X, Sang P, Xia YL, Li Y, Liang J, Ai SM, Ji XL, Fu YX, Liu SQ.
    J Biomol Struct Dyn; 2017 May 07; 35(7):1500-1517. PubMed ID: 27485684
    [Abstract] [Full Text] [Related]

  • 18. The role of structural flexibility and stability in the interaction of serine proteases with their inhibitors.
    Gráf L, Molnár T, Kardos J, Gáspári Z, Katona G.
    Curr Protein Pept Sci; 2015 May 07; 16(6):521-31. PubMed ID: 25921930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cleavage of peptidic inhibitors by target protease is caused by peptide conformational transition.
    Jiang L, Oldenburg E, Kromann-Hansen T, Xu P, Jensen JK, Andreasen PA, Huang M.
    Biochim Biophys Acta Gen Subj; 2018 Sep 07; 1862(9):2017-2023. PubMed ID: 29959058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.